Ambu A/S (LON:0MJF)
 104.73
 -0.94 (-0.89%)
  At close: Oct 29, 2025
Ambu A/S Revenue
Ambu A/S had revenue of 1.51B DKK in the quarter ending June 30, 2025, with 8.97% growth. This brings the company's revenue in the last twelve months to 5.96B, up 13.21% year-over-year. In the fiscal year ending September 30, 2024, Ambu A/S had annual revenue of 5.39B with 12.90% growth.
Revenue (ttm) 
 5.96B DKK
Revenue Growth 
 +13.21%
P/S Ratio 
 4.69
Revenue / Employee 
 1.15M DKK
Employees 
 5,196
Market Cap 
3.21B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Sep 30, 2024 | 5.39B | 616.00M | 12.90% | 
| Sep 30, 2023 | 4.78B | 331.00M | 7.45% | 
| Sep 30, 2022 | 4.44B | 431.00M | 10.74% | 
| Sep 30, 2021 | 4.01B | 446.00M | 12.50% | 
| Sep 30, 2020 | 3.57B | 747.00M | 26.49% | 
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 200.18B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 43.13B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 32.17B | 
| British American Tobacco p.l.c. | 25.60B |